These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11798506)

  • 1. A single-step colony-forming unit assay for unseparated mobilized peripheral blood, cord blood, and bone marrow.
    de Kreuk AM; Zevenbergen A; van Oostveen JW; Schuurhuis GJ; Huijgens PC; Jonkhoff AR
    J Hematother Stem Cell Res; 2001 Dec; 10(6):795-806. PubMed ID: 11798506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A; Xu G; Constantinescu D; Kashiwakura I; Farley T; Dobrila L; Rubinstein P; Adamson JW
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative sedimentation of hematopoietic progenitors in human cord blood, peripheral blood, and bone marrow as determined by counterflow centrifugal elutriation.
    Gengozian N; Hill RJ; Caudle MR; Panella TJ
    Transplantation; 1998 Apr; 65(7):939-46. PubMed ID: 9565099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood.
    Abe T; Ito M; Okamoto Y; Kim HJ; Takaue Y; Yasutomo K; Makimoto A; Yamaue T; Kawano Y; Watanabe T; Shimada T; Kuroda Y
    Exp Hematol; 1997 Aug; 25(9):966-71. PubMed ID: 9257810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in subjective review of umbilical cord blood colony forming unit assay.
    Powell K; Kwee E; Nutter B; Herderick E; Paul P; Thut D; Boehm C; Muschler G
    Cytometry B Clin Cytom; 2016 Nov; 90(6):517-524. PubMed ID: 27086577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative comparative analysis of gradient-separated hematopoietic cells from cord blood and chemotherapy-mobilized peripheral blood.
    Sato J; Kawano Y; Takaue Y; Hirao A; Makimoto A; Okamoto Y; Abe T; Shimokawa T; Iwai A; Kuroda Y
    Stem Cells; 1995 Sep; 13(5):548-55. PubMed ID: 8528105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.
    Almici C; Carlo-Stella C; Mangoni L; Garau D; Cottafavi L; Ventura A; Armanetti M; Wagner JE; Rizzoli V
    Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood plasma-mediated ex vivo expansion of hematopoietic progenitor cells.
    Bertolini F; Lazzari L; Lauri E; Corsini C; Sirchia G
    Bone Marrow Transplant; 1994 Sep; 14(3):347-53. PubMed ID: 7527688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
    Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
    J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S; Kawano Y; Watanabe T; Nakagawa R; Suzuya H; Onishi T; Yamazaki J; Nakayama T; Kuroda Y; Takaue Y
    Stem Cells; 2000; 18(3):190-5. PubMed ID: 10840072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do two different stem cell grafts: G-CSF stimulated and unstimulated bone marrow differ according to hematopoietic colony forming capacity?
    Özgüner M; Azık MF; Tavil B; Bozkaya I; Köksal Y; Canal E; Uçkan D; Tunç B
    Transfus Apher Sci; 2014 Jun; 50(3):467-72. PubMed ID: 24656491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.